Publications
69
Citations
1,240
Est. group size
~1
Recurring co-author estimate
Active years
19
Publishing since 2008
Luke V. Selby's research centers on surgical oncology, particularly the treatment and outcomes of gastrointestinal cancers such as colorectal, gastric, and peritoneal metastatic disease, often involving procedures like cytoreductive surgery combined with heated chemotherapy (CRS/HIPEC). Additional work examines quality measurement in surgery (e.g., 'textbook outcomes', volume-outcome relationships), melanoma immunotherapy approaches, and surgical education and training. This work is largely clinical and outcomes-focused, drawing on national cancer databases, systematic reviews, and case reports.
Publication output has fluctuated over the last decade, with a notable peak in 2020, a lull between 2021-2023, and renewed growth from 2024 through 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ASO Author Reflections: Writing the Textbook on “Textbook Outcomes” in Surgical Oncology
Annals of Surgical Oncology · 2026
- ASO Visual Abstract: The “Textbook Outcome” Isn’t Textbook: Significant Variation in “Textbook Outcome” Definitions After a Systematic Review of the Surgical Oncology Literature
Annals of Surgical Oncology · 2026
- Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis
Cancers · 2026
- Volume–Outcome Relationships in Total Mesorectal Excision Quality and Grading: A National Cancer Database Study
Annals of Surgical Oncology · 2026
- ASO Visual Abstract: Volume-Outcome Relationships in Total Mesorectal Excision Quality and Grading: A National Cancer Database Study
Annals of Surgical Oncology · 2026
- The “Textbook Outcome” Isn’t Textbook: Significant Variation in “Textbook Outcome” Definitions following a Systematic Review of the Surgical Oncology Literature
Annals of Surgical Oncology · 2025
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future
Cancers · 2025
- Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma
Future Oncology · 2025
- Fragmented but not necessarily flawed
The American Journal of Surgery · 2025
- Abstract 774: Deciphering the biology of colorectal metastasis to the peritoneal surface
Cancer Research · 2025
- Remission of Chimeric Antigen Receptor T-Cell-Refractory Diffuse Large B-Cell Lymphoma Resolved by Surgery and CD20 Bispecific Therapy
Cureus · 2025
- Missing data and missed opportunities: Inability to perform secondary analysis of prospective randomized control trials due to missing general anesthesia data.
Journal of Clinical Oncology · 2025
- Impact of KRAS mutation status on outcomes in peritoneal metastatic mucinous adenocarcinoma of the colon and appendix following CRS-HIPEC: A retrospective analysis.
Journal of Clinical Oncology · 2025
- Axillary Sentinel Lymph Node Biopsy for Cutaneous Melanoma: More Work Is Not Needed
Annals of Surgical Oncology · 2025
- Invited Commentary: Should We Be Doing Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma?
Journal of the American College of Surgeons · 2025
- Annals of Surgical Oncology×10
- Journal of the American College of Surgeons×5
- Journal of Surgical Oncology×4
- Journal of Surgical Research×3
- Cancers×3
- John M. Dewitt
Medicine · Indiana University
- Hongyu Gao
Medicine · Indiana University
- Fredy Nehme
Medicine · Indiana University
- Cho Hyun Park
Medicine · Purdue University West Lafayette
- Yuan Zhou
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile